Technical Analysis for BDX - Becton, Dickinson and Company

Grade Last Price % Change Price Change
grade D 247.01 1.92% 4.65
BDX closed up 1.92 percent on Wednesday, November 13, 2019, on 1.26 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Flat Down Down
See historical BDX trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Crossed Above 200 DMA Bullish 0.00%
Stochastic Buy Signal Bullish 0.00%
Cup with Handle Other 0.00%
Outside Day Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup 1.92%
Cup with Handle Other 1.92%
Calm After Storm Range Contraction 1.92%
Outside Day Range Expansion 1.92%

Older signals for BDX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. This segment's products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment's products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company's BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment's products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.
Medicine Biotechnology Biology Pharmaceutical Industry Infectious Diseases Diabetes Antibodies Cancers New Jersey Medical Technology Catheters Medical Tests Medical Devices Drug Delivery Healthcare Associated Infections Treatment Of Diabetes Healthcare Institutions Syringe Drug Delivery Systems Laboratory Products Clinical Tools Becton
Is BDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 264.74
52 Week Low 208.62
Average Volume 1,100,404
200-Day Moving Average 246.795
50-Day Moving Average 252.665
20-Day Moving Average 250.6566
10-Day Moving Average 249.484
Average True Range 5.2021
ADX 15.37
+DI 19.3081
-DI 25.0191
Chandelier Exit (Long, 3 ATRs ) 246.0837
Chandelier Exit (Short, 3 ATRs ) 256.2163
Upper Bollinger Band 262.3143
Lower Bollinger Band 238.9989
Percent B (%b) 0.34
BandWidth 9.30173
MACD Line -1.8897
MACD Signal Line -0.9567
MACD Histogram -0.933
Fundamentals Value
Market Cap 56.21 Billion
Num Shares 228 Million
EPS 3.45
Price-to-Earnings (P/E) Ratio 71.60
Price-to-Sales 3.93
Price-to-Book 3.79
PEG Ratio 2.05
Dividend 2.92
Dividend Yield 1.18%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 256.64
Resistance 3 (R3) 255.58 251.30 255.04
Resistance 2 (R2) 251.30 248.85 251.84 254.50
Resistance 1 (R1) 249.16 247.34 250.23 250.22 253.96
Pivot Point 244.88 244.88 245.42 245.42 244.88
Support 1 (S1) 242.74 242.43 243.81 243.80 240.06
Support 2 (S2) 238.46 240.92 239.00 239.52
Support 3 (S3) 236.32 238.46 238.99
Support 4 (S4) 237.38